The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Been through a few links and my guess Alan Miller is, according to his Twitter account bio 'Chief Medical director of Oncology for the SCL Health System in Colorado and Montana'. He's also followed by ASCO, of which we of course attended their annual meeting in the summer.
Correct mcadder, think it's the Feb '22 Hardman note that states net cash at the end of '22 calender year should be £600k+. Anyway, i bought more this morning, currently holding more than 6x £ value in shares down here sub 1.5p than i was on relisting at 10p.
Should be at £15-30m market cap even in a bear market
The £1m off St GeorgeSC is expected to come in 2022, and the cash burn for a diagnostic tool company is considerably small compared to others. Remember, Syms said he sees Ciz as 'very much a virtual company'. Much of the development etc is outsourced, whilst giving out a share of the pie in return, a large share it would appear in China, but give me smaller piece all day over being diluted to oblivion.
Can't knock the Companys strategy so far, even if the SP is shocking. That being said, i wouldn't mind some Director buys down here...
Sharepads data appears to say that University of York sold their 8.2m/3.14% and Finance Yorkshire Seedcom sold their 24.4m/9.36%.
No holdings RNS on these two as far as i'm aware, unsure if these disposals are true and how Sharepad would know without RNS'.
Seems a bit odd
Sharepads data appears to say that University of York sold their 8.2m/3.14% and Finance Yorkshire Seedcom sold their 24.4m/9.36%.
No holdings RNS on these two as far as i'm aware, unsure if these disposals are true and how Sharepad would know without RNS'.
Seems a bit odd
Bought yesterday at 5.55 on a darvas box breakout on the chart, the trend is your friend and the trend is UP
Looking back at my notes during the webinar last May upon listing, it's unsuprising to see such progress being made in China, with Allan stating he was on good terms with the Chinese Minister for Health.
I also noted that the NHS was Cizzles initial target market, who knows what other deals are lurking on the horizon?
Jumping the gun a bit but i've noticied in the past that some potential takeover bids have had to be placed at or above the 12 month SP high. Is this only the case when another company buys up 30% on the open market and have to make an offer?
Regardless, i bought in earlier after watching THG for what seems like an age! GL all
Bourbon Rainbow has been at Shells Graff 1 for a while, Bourbon Ruby was as well but left a couple of days ago for Namibian port Walvis Bay. Bourbon Calm is currently heading for Graff 1 now. Plenty still going on!
Upstream has around 10,000 paid subscribers, it's hardly some tinpot clickbait website.
The Shell Namibia news is the main headline now. Looking forward to see more coverage as they drill for the primary target!
Ask being smashed by large buyers
Everytime for the last 18 months i mention a potentially new, great investment opportunity to my other half, i've had the response "what, like Bould Opportunities?".
Tomorrow is a new day and those sarcastic comments won't be missed. GL for tomorrow fellow Cizzlers